Background The efficacy of interleukin-6 receptor antagonists in critically ill patients with
coronavirus disease 2019 (Covid-19) is unclear. Methods We evaluated tocilizumab and …

Background Studies that have evaluated the use of intravenous vitamin C in adults with
sepsis who were receiving vasopressor therapy in the intensive care unit (ICU) have shown …

BACKGROUND: Nasal high-flow oxygen therapy increases the mean nasopharyngeal
airway pressure in adults, but the relationship between flow and pressure is not well defined. …

We conducted a multinational, randomized, controlled trial involving critically ill patients with
severe acute kidney injury. Patients were randomly assigned to receive an accelerated …

BACKGROUND: Nasal high flow (NHF) oxygen therapy and CPAP are modes of noninvasive
respiratory support used to improve respiratory function in multiple patient groups. Both …

OBJECTIVE: In a cardiothoracic and vascular intensive care unit, to compare nasal high-flow
(NHF) oxygen therapy and standard high-flow face mask (HFFM) oxygen therapy in …

BACKGROUND: Previous research has demonstrated a positive linear correlation between
flow delivered and airway pressure generated by high-flow nasal therapy. Current practice is …

Importance Proton pump inhibitors (PPIs) or histamine-2 receptor blockers (H 2 RBs) are
often prescribed for patients as stress ulcer prophylaxis drugs in the intensive care unit (ICU). …

Background Acute kidney injury is common in critically ill patients, many of whom receive
renal-replacement therapy. However, the most effective timing for the initiation of such therapy …

BACKGROUND The interleukin-6 receptor antagonist tocilizumab improves outcomes in
critically ill patients with coronavirus disease 2019 (COVID-19). However, the effectiveness of …